Currently Viewing:
Currently Reading
Polypharmacy Plays a Role in Patients With Relapsing-Remitting Multiple Sclerosis
February 17, 2019 – Laura Joszt
Review Find Moderate Evidence That Aerobic Exercise Lowers Number of Migraine Days
February 16, 2019 – Jaime Rosenberg
Continuous Fingolimod Treatment Leads to 50% Reduction of ARRs
February 15, 2019 – Samantha DiGrande
CMS Proposes That Patients Be Enrolled in Studies to Get Coverage for CAR T-Cell Therapy
February 15, 2019 – Mary Caffrey and Allison Inserro
What We're Reading: Syphilis Rates Rising; House Democrats and ACA Suit; WHO to Look at Gene Editing
February 15, 2019 – AJMC Staff
HCCI Report: Healthcare Spending Increased Even as Utilization Decreased or Stagnated
February 15, 2019 – Wallace Stephens
AJMC® in the Press, February 15, 2019
February 15, 2019 – AJMC Staff
5 Findings From the February 2019 Issue of AJMC®
February 15, 2019 – Christina Mattina
This Week in Managed Care: February 15, 2019
February 15, 2019

Azar Appoints Senior Advisor for Value-Based Care in the United States

Laura Joszt
Adam Boehler, director of the Center for Medicare & Medicaid Innovation, is taking on an additional role as the senior advisor for value-based transformation and innovation. He represents the last departmental appointment as part of HHS Secretary Alex Azar's 4 priority areas.
Adam Boehler, who is currently director of the Center for Medicare & Medicaid Innovation (CMMI), will take on a new role that will help transform the US healthcare system to a value-based one. HHS Secretary Alex Azar announced that Boehler will also serve as the senior advisor for value-based transformation and innovation.

In March, Azar had announced 4 initiatives that were key departmental priorities: combatting the opioid crisis, bringing down the cost of prescription drugs, addressing the cost and availability of health insurance, and value-based transformation of the healthcare system.

“Adam is the kind of results-oriented, transformational leader we need to deliver on what President Trump has promised the American people: better healthcare at a lower cost,” Azar said in a statement. “At CMMI, he has already demonstrated an ambition for bold change, and will now be able to bring his deep experience with private sector innovation to help HHS execute on the long-talked-about goal of transforming our healthcare system into one that pays for value.”

Boehler represents the last senior advisor to be named to the 4 priority areas. Previously, Jim Parker was named senior advisor to the secretary for health reform and director of the Office of Health Reform, Dan Best was named senior advisor for drug pricing reform, and Brett Giroir, MD, was named senior advisor for opioid and mental health policy.

Boehler will continue to lead CMMI, which pilots, tests, and evaluates alternative payment models. He was previously the CEO and founder of Landmark Health, which was created to transform healthcare by improving quality of life in communities.

On Twitter, Boehler wrote that he was excited to expand HHS’ “efforts to move healthcare from volume to value for the benefit of the American patient.”

Charles “Chip” Kahn III, president and CEO of the Federation of American Hospitals, wrote in a blog post that Boehler has been an actual innovator and brings a fresh take on healthcare.

“I believe he is well suited for his new role as Senior Advisor for Value-Based Transformation and Innovation,” Kahn wrote.

America’s Physician Groups, which represents accountable physician groups that aim to drive the transformation of healthcare delivery, applauded the appointment.

As the transition to value is a top priority for Secretary Azar and an integral component in bending the healthcare cost curve, it is critical that HHS has an experienced and forward-leaning individual leading this effort,” Donald H. Crane, president and CEO of America’s Physician Groups, said in a statement. “Mr. Boehler is such an individual.”

FDA Commissioner Scott Gottlieb, MD, noted his support of Boehler’s new appointment.

Related Articles

Value-Based Partnerships: Engaging in Value-Driven Innovative Collaborations
Report: Value-Based Care Strategies Effective, but Payers Struggle to Roll Them Out Quickly
Value-Based Payment Models Not Yet Reaching Full Potential, Study Says
Dr Clifford Goodman on Progress With the Move to Value-Based Payments
Doctors, Payers Think Transition to Value-Based Care Has Slowed, Survey Says
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!